These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 27233280

  • 1. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA, Moi ML, Takasaki T.
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG, Salje H, Macareo LR, Hermann LL, Nisalak A, Srikiatkhachorn A.
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
    Chua CL, Sam IC, Merits A, Chan YF.
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus.
    Lin HC, Chang SF, Su CL, Hu HC, Chiao DJ, Hsu YL, Lu HY, Lin CC, Shu PY, Kuo SC.
    BMC Infect Dis; 2024 Sep 30; 24(1):1076. PubMed ID: 39350079
    [Abstract] [Full Text] [Related]

  • 11. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C, Büchner SM, Schnierle BS.
    PLoS Negl Trop Dis; 2015 Apr 30; 9(4):e0003684. PubMed ID: 25905779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.
    Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PV.
    Vaccine; 2009 Apr 21; 27(18):2513-22. PubMed ID: 19368794
    [Abstract] [Full Text] [Related]

  • 14. A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
    Goo L, Dowd KA, Lin TY, Mascola JR, Graham BS, Ledgerwood JE, Pierson TC.
    J Infect Dis; 2016 Nov 15; 214(10):1487-1491. PubMed ID: 27655868
    [Abstract] [Full Text] [Related]

  • 15. Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay.
    Moi ML, Takasaki T.
    Methods Mol Biol; 2016 Nov 15; 1426():143-52. PubMed ID: 27233268
    [Abstract] [Full Text] [Related]

  • 16. A Plaque Reduction Neutralization Test for the Detection of ZIKV-Specific Antibodies.
    Dimitrova K, Mendoza EJ, Mueller N, Wood H.
    Methods Mol Biol; 2020 Nov 15; 2142():59-71. PubMed ID: 32367358
    [Abstract] [Full Text] [Related]

  • 17. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies.
    Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE.
    J Virol Methods; 2010 Jan 15; 163(1):153-6. PubMed ID: 19761798
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of Neutralization Assay Using an eGFP Chikungunya Virus.
    Deng CL, Liu SQ, Zhou DG, Xu LL, Li XD, Zhang PT, Li PH, Ye HQ, Wei HP, Yuan ZM, Qin CF, Zhang B.
    Viruses; 2016 Jun 28; 8(7):. PubMed ID: 27367716
    [Abstract] [Full Text] [Related]

  • 20. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
    Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A.
    J Immunol; 2011 Mar 01; 186(5):3258-64. PubMed ID: 21278338
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.